Chemoinformaics analysis of (E)-oct-2-enoic acid
| Molecular Weight | 142.198 | nRot | 5 |
| Heavy Atom Molecular Weight | 128.086 | nRig | 0 |
| Exact Molecular Weight | 142.099 | nRing | 0 |
| Solubility: LogS | 0.644 | nHRing | 0 |
| Solubility: LogP | 0.42 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 24.2991 |
| nHD | 1 | BPOL | 14.9129 |
| QED | 0.552 |
| Synth | 2.618 |
| Natural Product Likeliness | 0.425 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.003 |
| HIA | 0.001 |
| CACO-2 | -4.1 |
| MDCK | 0.000448572 |
| BBB | 0.55 |
| PPB | 0.150207 |
| VDSS | 1.189 |
| FU | 0.771472 |
| CYP1A2-inh | 0.032 |
| CYP1A2-sub | 0.62 |
| CYP2c19-inh | 0.02 |
| CYP2c19-sub | 0.818 |
| CYP2c9-inh | 0.004 |
| CYP2c9-sub | 0.096 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.141 |
| CYP3a4-inh | 0.005 |
| CYP3a4-sub | 0.123 |
| CL | 6.78 |
| T12 | 0.87 |
| hERG | 0.082 |
| Ames | 0.085 |
| ROA | 0.011 |
| SkinSen | 0.147 |
| Carcinogencity | 0.128 |
| EI | 0.974 |
| Respiratory | 0.012 |
| NR-Aromatase | 0.006 |
| Antiviral | No |
| Prediction | 0.954314 |